Escalon Medical Corp.
ESMC
$0.19
-$0.02-9.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.59M | 2.68M | 2.57M | 3.47M | 3.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.59M | 2.68M | 2.57M | 3.47M | 3.22M |
| Cost of Revenue | 2.04M | 1.55M | 1.45M | 1.87M | 1.65M |
| Gross Profit | 1.56M | 1.12M | 1.12M | 1.60M | 1.57M |
| SG&A Expenses | 1.33M | 1.11M | 1.20M | 1.16M | 1.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.49M | 2.88M | 2.94M | 3.20M | 2.96M |
| Operating Income | 98.70K | -202.80K | -371.80K | 276.00K | 255.90K |
| Income Before Tax | 97.70K | -239.90K | -379.80K | 271.50K | 246.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 97.70K | -239.90K | -379.80K | 271.50K | 246.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.70K | -239.90K | -379.80K | 271.50K | 246.00K |
| EBIT | 98.70K | -202.80K | -371.80K | 276.00K | 255.90K |
| EBITDA | 107.20K | -194.60K | -363.20K | 284.80K | 265.80K |
| EPS Basic | 0.01 | -0.03 | -0.03 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.01 | -0.02 | -0.03 | 0.02 | 0.02 |
| EPS Diluted | 0.01 | -0.03 | -0.03 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.00 | -0.02 | -0.03 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M |
| Average Diluted Shares Outstanding | 14.42M | 7.42M | 7.42M | 14.17M | 14.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |